HighTower Advisors, LLC - SYNERGY PHARMACEUTICALS DEL ownership

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$5,000
-99.8%
49,831
-97.3%
0.00%
-100.0%
Q3 2018$3,183,000
+101.7%
1,875,128
+106.3%
0.02%
+91.7%
Q2 2018$1,578,000
-5.6%
908,946
-0.8%
0.01%
-14.3%
Q1 2018$1,672,000
-6.8%
916,058
+10.8%
0.01%
-6.7%
Q4 2017$1,794,000
-26.6%
826,882
-2.2%
0.02%
-28.6%
Q3 2017$2,444,000
-31.5%
845,264
+5.0%
0.02%
-34.4%
Q2 2017$3,570,000
+7.4%
805,006
+12.6%
0.03%0.0%
Q1 2017$3,325,000
-33.8%
715,048
-13.3%
0.03%
-41.8%
Q4 2016$5,022,000
+0.7%
824,949
-8.9%
0.06%
-5.2%
Q3 2016$4,988,000
+44.8%
905,764
-0.1%
0.06%
+31.8%
Q2 2016$3,444,000
+45.3%
906,748
+5.5%
0.04%
+450.0%
Q1 2016$2,370,000
+188.7%
859,609
+492.9%
0.01%
-20.0%
Q4 2015$821,000
-48.7%
144,994
-52.0%
0.01%
-52.4%
Q3 2015$1,600,000
+164.9%
302,316
+315.4%
0.02%
+110.0%
Q2 2015$604,000
-55.2%
72,778
-75.1%
0.01%
-50.0%
Q1 2015$1,349,000
-21.7%
292,034
-48.3%
0.02%
-23.1%
Q4 2014$1,722,000
+68.5%
564,427
+53.8%
0.03%
+52.9%
Q3 2014$1,022,000
-25.2%
367,101
+9.3%
0.02%
-29.2%
Q2 2014$1,366,000
-27.3%
335,732
-5.2%
0.02%
-35.1%
Q1 2014$1,880,000
+29.6%
354,026
+37.4%
0.04%
+23.3%
Q4 2013$1,451,000
+31.2%
257,690
+6.5%
0.03%
+7.1%
Q3 2013$1,106,000
+65.1%
242,001
+56.0%
0.03%
+55.6%
Q2 2013$670,000155,0870.02%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2023
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 477,621$1,065,0001.44%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,804$3,358,0001.18%
Nantahala Capital Management 7,000,000$15,610,0000.69%
Hikari Power Ltd 1,900,000$4,237,0000.50%
Trellus Management Company, LLC 112,500$251,0000.34%
Cheyne Capital Management (UK) LLP 206,500$462,0000.20%
KNOTT DAVID M 201,400$449,0000.18%
Paulson & Co. 4,000,000$8,920,0000.17%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,041,695$2,323,0000.15%
Clear Harbor Asset Management, LLC 318,460$710,0000.13%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders